FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 67 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,596,000 | +27.7% | 525,000 | 0.0% | 0.08% | +55.8% |
| Q2 2019 | $1,250,000 | +11.1% | 525,000 | +75.0% | 0.05% | +26.8% |
| Q1 2019 | $1,125,000 | +4.5% | 300,000 | 0.0% | 0.04% | -44.6% |
| Q4 2018 | $1,077,000 | +870.3% | 300,000 | +1257.5% | 0.07% | +825.0% |
| Q2 2018 | $111,000 | -96.7% | 22,100 | -96.7% | 0.01% | -98.5% |
| Q1 2017 | $3,324,000 | – | 670,400 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 20,150 | $0 | 0.00% |
| Advisory Services Network, LLC | 2,233 | $0 | 0.00% |
| Fernwood Investment Management, LLC | 34,000 | $0 | 0.00% |